Skip to main navigation Skip to search Skip to main content

Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study

LITESPARK-004 Investigator Group - Ocular VHL

Research output: Contribution to journal › Article › peer-review

13   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry